NUK - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov NUK. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 97
1.
  • The fully synthetic glycope... The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients
    Rosenbaum, Pierre; Artaud, Cécile; Bay, Sylvie ... Cancer Immunology, Immunotherapy, 05/2020, Letnik: 69, Številka: 5
    Journal Article
    Recenzirano
    Odprti dostop

    Cancer is one of the main causes of mortality worldwide and a major public health concern. Among various strategies, therapeutic vaccines have been developed to stimulate anti-tumoral immune ...
Celotno besedilo
2.
  • First-line chemoimmunothera... First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
    Brignone, Chrystelle; Gutierrez, Maya; Mefti, Fawzia ... Journal of translational medicine, 07/2010, Letnik: 8, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    IMP321 is a recombinant soluble LAG-3Ig fusion protein that binds to MHC class II with high avidity and mediates APC and then antigen-experienced memory CD8+ T cell activation. We report clinical and ...
Celotno besedilo

PDF
3.
  • A randomized, placebo-contr... A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
    Goldstein, Lori J.; Mansutti, Mauro; Levy, Christelle ... Breast cancer research and treatment, 11/2021, Letnik: 190, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    Purpose CXCR1, one of the receptors for CXCL8, has been identified as a druggable target on breast cancer cancer stem cells (CSC). Reparixin (R), an investigational oral inhibitor of CXCR1, was ...
Celotno besedilo

PDF
4.
  • Retrospective analysis of r... Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study)
    Leroy, Karen; Audigier Valette, Clarisse; Alexandre, Jérôme ... PloS one, 09/2023, Letnik: 18, Številka: 9
    Journal Article
    Recenzirano
    Odprti dostop

    Considering the growing interest in matched cancer treatment, our aim was to evaluate the ability of a comprehensive genomic profiling (CGP) assay to propose at least one targeted therapy given an ...
Celotno besedilo
5.
Celotno besedilo
6.
  • Association between Olapari... Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
    Velev, Maud; Puszkiel, Alicja; Blanchet, Benoit ... Pharmaceuticals, 08/2021, Letnik: 14, Številka: 8
    Journal Article
    Recenzirano
    Odprti dostop

    Factors associated with olaparib toxicity remain unknown in ovarian cancer patients. The large inter-individual variability in olaparib pharmacokinetics could contribute to the onset of early ...
Celotno besedilo

PDF
7.
  • Ovarian cancer: sites of re... Ovarian cancer: sites of recurrence
    Amate, Pascale; Huchon, Cyrille; Dessapt, Anne Lucie ... International journal of gynecological cancer, 2013-November, Letnik: 23, Številka: 9
    Journal Article
    Recenzirano
    Odprti dostop

    Improved knowledge of recurrence sites after contemporary surgical management of ovarian cancer is needed. We retrospectively reviewed consecutive patients managed for epithelial ovarian or tubal ...
Celotno besedilo
8.
  • Prospective Multicenter Pha... Prospective Multicenter Phase II Study of Gemcitabine Plus Platinum Salt for Metastatic Collecting Duct Carcinoma: Results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) Study
    Oudard, Stéphane; Banu, Eugeniu; Vieillefond, Annick ... The Journal of urology, 05/2007, Letnik: 177, Številka: 5
    Journal Article
    Recenzirano

    Purpose Collecting duct carcinoma of the kidney is a rare and aggressive neoplasm of the distal collecting tubules for which there is no established treatment. Since the histology of collecting duct ...
Celotno besedilo
9.
  • Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients
    Dupuis-Girod, Sophie; Medioni, Jacques; Haddad, Elie ... Pediatrics (Evanston), 05/2003, Letnik: 111, Številka: 5 Pt 1
    Journal Article
    Recenzirano

    To evaluate the occurrence of autoimmune and inflammatory complications in Wiskott-Aldrich syndrome (WAS) and to determine risk factors and the prognosis of such complications with the aim of ...
Preverite dostopnost
10.
Celotno besedilo
1 2 3 4 5
zadetkov: 97

Nalaganje filtrov